Anne Samuel
Stock Analyst at JP Morgan
(2.49)
# 2,338
Out of 5,124 analysts
67
Total ratings
54.55%
Success rate
0.03%
Average return
Main Sectors:
Stocks Rated by Anne Samuel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Maintains: Overweight | $13 → $7 | $4.00 | +75.00% | 13 | Nov 17, 2025 | |
| HQY HealthEquity | Maintains: Overweight | $125 → $126 | $91.61 | +37.54% | 9 | Sep 3, 2025 | |
| VEEV Veeva Systems | Maintains: Neutral | $274 → $290 | $223.23 | +29.91% | 7 | Aug 28, 2025 | |
| PGNY Progyny | Maintains: Neutral | $23 → $25 | $25.68 | -2.65% | 8 | Aug 26, 2025 | |
| DOCS Doximity | Maintains: Neutral | $63 → $60 | $44.28 | +35.50% | 7 | May 27, 2025 | |
| IQV IQVIA Holdings | Maintains: Overweight | $232 → $177 | $225.41 | -21.48% | 7 | May 19, 2025 | |
| OMCL Omnicell | Maintains: Neutral | $44 → $36 | $45.30 | -20.53% | 5 | Mar 20, 2025 | |
| PHR Phreesia | Maintains: Overweight | $27 → $28 | $16.92 | +65.48% | 2 | Sep 9, 2024 | |
| CCSI Consensus Cloud Solutions | Downgrades: Underweight | $19 → $21 | $21.82 | -3.76% | 3 | Sep 9, 2024 | |
| HCAT Health Catalyst | Maintains: Overweight | $10 → $13 | $2.39 | +443.93% | 3 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $27 | $32.75 | -17.56% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $7 → $5 | $2.88 | +73.61% | 1 | Jul 31, 2024 |
Evolent Health
Nov 17, 2025
Maintains: Overweight
Price Target: $13 → $7
Current: $4.00
Upside: +75.00%
HealthEquity
Sep 3, 2025
Maintains: Overweight
Price Target: $125 → $126
Current: $91.61
Upside: +37.54%
Veeva Systems
Aug 28, 2025
Maintains: Neutral
Price Target: $274 → $290
Current: $223.23
Upside: +29.91%
Progyny
Aug 26, 2025
Maintains: Neutral
Price Target: $23 → $25
Current: $25.68
Upside: -2.65%
Doximity
May 27, 2025
Maintains: Neutral
Price Target: $63 → $60
Current: $44.28
Upside: +35.50%
IQVIA Holdings
May 19, 2025
Maintains: Overweight
Price Target: $232 → $177
Current: $225.41
Upside: -21.48%
Omnicell
Mar 20, 2025
Maintains: Neutral
Price Target: $44 → $36
Current: $45.30
Upside: -20.53%
Phreesia
Sep 9, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $16.92
Upside: +65.48%
Consensus Cloud Solutions
Sep 9, 2024
Downgrades: Underweight
Price Target: $19 → $21
Current: $21.82
Upside: -3.76%
Health Catalyst
Sep 4, 2024
Maintains: Overweight
Price Target: $10 → $13
Current: $2.39
Upside: +443.93%
Aug 19, 2024
Maintains: Overweight
Price Target: $24 → $27
Current: $32.75
Upside: -17.56%
Jul 31, 2024
Downgrades: Underweight
Price Target: $7 → $5
Current: $2.88
Upside: +73.61%